Drugs / Autologous HPV6 E6-and E7-derived peptide-loaded dendritic cell
Autologous HPV6 E6-and E7-derived peptide-loaded dendritic cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07317154 | Sep 2026 → Jun 2027 expected | recurrent respiratory papillomatosis | Mayo Clinic | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous HPV6 E6-and E7-derived peptide-loaded dendritic cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07317154 ↗ |
| Modality | Cell therapy | “Peptide-loaded Autologous Dendritic Cell Vaccination” NCT07317154 ↗ |